Sinopharm Group
Chinese biotechnology company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Sinopharm Group?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Not to be confused with Sinopharm, the short name of the parent company China National Pharmaceutical Group.
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Quick Facts Company type, Traded as ...
Company type | public | ||||
---|---|---|---|---|---|
| |||||
ISIN | CNE100000FN7 | ||||
Industry | Pharmaceutical | ||||
Founded |
| ||||
Founder | China National Pharmaceutical Group | ||||
Headquarters | Sinopharm Plaza, , China | ||||
Area served | China | ||||
Key people |
| ||||
Revenue | CN¥227.069 billion (2015) | ||||
CN¥9.169 billion (2015) | |||||
CN¥3.761 billion (2015) | |||||
Total assets | CN¥138.267 billion (2015) | ||||
Total equity | CN¥30.052 billion (2015) | ||||
Owner | Sinopharm Industrial Investment (56.79%) | ||||
Parent | Sinopharm Industrial Investment | ||||
Subsidiaries | Sinopharm CNMC | ||||
Footnotes / references in a consolidated basis; equity and profit excluded minority interests; in Hong Kong Financial Reporting Standards[1] |
Close
Quick Facts Simplified Chinese, Traditional Chinese ...
Sinopharm Group Co., Ltd. | |||
---|---|---|---|
Simplified Chinese | 国药控股股份有限公司 | ||
Traditional Chinese | 國藥控股股份有限公司 | ||
Literal meaning | Sinopharm Holding Joint-Stock Limited Company | ||
| |||
Sinopharm Group | |||
Simplified Chinese | 国药控股 | ||
Traditional Chinese | 國藥控股 | ||
Literal meaning | Sinopharm Holding | ||
| |||
Second alternative Chinese name | |||
Simplified Chinese | 国控股份有限公司 | ||
Traditional Chinese | 國控股份有限公司 | ||
| |||
Close
Its H shares were listed on the Hong Kong Stock Exchange in 2009,[2] with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list.[3]